Drug profile · INN
riboflavin 5'-phosphate sodium
PHOTREXA VISCOUS IN DEXTRAN 20%/PHOTREXA
riboflavin 5'-phosphate sodium (PHOTREXA VISCOUS IN DEXTRAN 20%/PHOTREXA) is a unknown. Route of administration: ophthalmic. Current US regulatory status: approved.
Drug details — riboflavin 5'-phosphate sodium
- US status
- approved
- Class
- —
- Route
- OPHTHALMIC
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
riboflavin 5'-phosphate sodium (PHOTREXA VISCOUS IN DEXTRAN 20%/PHOTREXA) is a unknown. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
Mechanism of action
Unknown
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is riboflavin 5'-phosphate sodium?
riboflavin 5'-phosphate sodium (PHOTREXA VISCOUS IN DEXTRAN 20%/PHOTREXA) is a unknown. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for riboflavin 5'-phosphate sodium?
PHOTREXA VISCOUS IN DEXTRAN 20%/PHOTREXA is a marketed brand name for riboflavin 5'-phosphate sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of riboflavin 5'-phosphate sodium?
riboflavin 5'-phosphate sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.